Study guide

13.2 Supply Chain Management

FACHE Board of Governors Exam in Healthcare Management Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the FACHE Credential 1.2 Current Exam Facts 1.3 Eligibility, Application & Recertification

2 Healthcare Systems & Trends

2.1 Healthcare and Medical Terminology 2.2 Healthcare Trends 2.3 Continuum of Care Levels

3 Healthcare Organizations & Services

3.1 Levels of Service from a Business Perspective 3.2 Types of Healthcare Organizations 3.3 Ancillary and Support Services

4 Integration, Clinicians & Staff Perspectives

4.1 Integration, Competition & Partnerships 4.2 Clinician Roles and Qualifying Criteria 4.3 Staff Perspectives & Evidence-Based Management

5 Patient Perspective & Care Delivery

5.1 Patient vs Provider Perspective 5.2 Access, Quality, Cost & Community 5.3 Care Delivery Models and Access Points

6 Digital Health, Population Health & Prevention

6.1 Digital Health 6.2 Population Health Concepts 6.3 Social Determinants & Preventative Medicine

7 Management Planning & Organizational Systems

7.1 Implementation Planning 7.2 Emergency Preparedness & NIMS 7.3 Organizational Systems & Management Functions

8 Leadership, Teams & Change

8.1 Leadership and Communication Styles 8.2 Team-Building Techniques 8.3 Change Management & Organizational Development

9 Collaboration, DEIJ & Networks

9.1 Stakeholder Collaboration 9.2 DEIJ & Resource Allocation 9.3 Network Structures & Collective Bargaining

10 Financial Accounting & Budgeting

10.1 Financial Accounting and Ratios 10.2 Operating Budgets 10.3 Capital Budgeting

11 Reimbursement, Productivity & Controls

11.1 Reimbursement Methodologies 11.2 Productivity Measures 11.3 Financial Controls

12 Revenue, Business Cases & Capital Finance

12.1 Revenue Generation and Payer Mix 12.2 Business Cases & Financial Decision Impacts 12.3 Asset Management & Financing

13 Philanthropy, Supply Chain & Revenue Cycle

13.1 Philanthropy and Foundations 13.2 Supply Chain Management 13.3 Revenue Cycle

14 HR Laws, Recruitment & Staffing

14.1 HR Laws and Regulations 14.2 Recruitment and Retention 14.3 Staffing Methodologies

15 Performance, Engagement & Compensation

15.1 Performance Management Systems 15.2 Motivation, Development & Engagement 15.3 Compensation and Benefits

16 Workplace Safety, Conflict & Labor Relations

16.1 Employee Safety, Security & Health 16.2 Conflict, Grievances & Selection 16.3 Labor Relations & HR Decision Impacts

17 Job Design, Succession & Coaching

17.1 Job Design 17.2 Succession Planning, Mentorship & Coaching

18 Confidentiality, Compliance & Payment Rules

18.1 Confidentiality and Privacy Laws 18.2 Healthcare Compliance Laws 18.3 Medicare, Medicaid & Third-Party Payment Regulations

19 Accreditation, Patient Rights & Ownership Rules

19.1 Accreditation & Inspection Standards 19.2 Patients' Rights Laws 19.3 Nonprofit vs For-Profit Requirements

20 Regulatory Impacts, Labor Law & M&A

20.1 Regulatory Impact on Executive Decisions 20.2 Collective Bargaining Laws 20.3 Legal Implications of Mergers & Acquisitions

21 Benchmarking, Peer Review & Risk

21.1 Benchmarking & Best Practices 21.2 Medical Staff Peer Review 21.3 Risk Management Programs

22 Improvement Methods & Measurement

22.1 PDSA, Lean & Six Sigma 22.2 Clinical Performance Improvement & Pathways 22.3 Quality Measurement & HCAHPS

23 Utilization, Patient Safety & Quality Impacts

23.1 Utilization Review & Case Management 23.2 Patient Safety Tools 23.3 How Quality Impacts Operations

24 Strategic Planning, Business Planning & Contracts

24.1 Strategic Planning Process 24.2 Business Planning for Services 24.3 Business Contracts

25 Socioeconomic Context, Marketing & Media

25.1 Socioeconomic Environment 25.2 Marketing Principles 25.3 Media, Social Media & Community Relations

26 Negotiation & Business Decision Impacts

26.1 Contract Negotiation 26.2 Business Decision Impacts

27 Health IT Operations, Trends & Regulation

27.1 IT in Business Operations 27.2 Technology Trends & Clinical Applications 27.3 HIPAA Security, HITECH & Interoperability

28 Informatics, IT Impacts & Continuity

28.1 Health Informatics for Operational Decisions 28.2 IT Decision Impacts 28.3 Information Systems Continuity

29 IT Acquisition & Analytics

29.1 IT Selection, Acquisition & Maintenance 29.2 Healthcare Analytics & Clinical Informatics

30 ACHE Ethics, Patient Rights & Ethics Committees

30.1 ACHE Code of Ethics 30.2 Patients' Rights & Responsibilities 30.3 Ethics Committees

31 Diversity, Conflicts of Interest & Research Ethics

31.1 Cultural & Spiritual Diversity 31.2 Conflict of Interest 31.3 Unethical Actions & Human-Subject Research

32 Professional Norms, Ethical Culture & Diversity Statement

32.1 Professional Norms & Standards 32.2 Creating an Ethical Culture 32.3 ACHE Statement on Diversity

33 Governance Theory, Structure & Medical Staff

33.1 Governance Theory 33.2 Governance Structure & Operations 33.3 Medical Staff Structure

34 Board Accountability & Public Policy

34.1 Board Role, Accountability & Fiduciary Duty 34.2 Public Policy & Advocacy

13.2 Supply Chain Management

Key Takeaways Explain This Topic AI

Healthcare supply chain covers sourcing, contracting, inventory, logistics, sterile processing interfaces, and point-of-use consumption for clinical and non-clinical goods

Structure typically combines centralized contracting/GPO strategy with local materials management, clinical value analysis, and service-line engagement

Effectiveness is monitored with cost-per-case, contract compliance, fill rates, inventory turns, stockouts, waste/expiry, and clinician preference alignment

Strategic decisions include make-vs-buy, single-vs-multi source, GPO participation, standardization, vendor-managed inventory, and resiliency vs. lowest unit price

FACHE executives link supply chain to quality, infection prevention, working capital, and disruption risk—not only purchase-price variance

Last updated: August 2026

Supply Chain Management

Quick Answer: Healthcare supply chain management is the end-to-end design of how products and related services are specified, sourced, contracted, stored, distributed, used, and paid for. Leaders build systems and structures , run reliable processes , monitor effectiveness , and make strategic decisions about standardization, vendors, inventory, and resilience. FACHE Finance F13 tests executive literacy—not warehouse clerk skills.

Supplies and purchased services are among the largest controllable non-labor expenses. Implants, pharmaceuticals, PPE, reagents, food, and IT hardware also shape quality, throughput, and patient safety. A stockout cancels cases; an uncontrolled implant preference card destroys contribution margin; a fragile single-source contract becomes a crisis in a pandemic or port disruption. Fellows must see supply chain as a strategic operating system .

  • Systems, Structures, and Processes
  • Core process chain

Typical flow:

  • Demand / specification — clinical protocols, preference cards, formulary, capital equipment needs
  • Sourcing and contracting — RFP, GPO contracts, local negotiation, value analysis
  • Ordering — requisitions, ERP/MMIS, automated replenishment, consignment
  • Receiving and inventory — docks, storerooms, PAR levels, RFID/barcode, cold chain
  • Distribution to point of use — OR suites, floors, clinics, pharmacies
  • Consumption and documentation — case costing, charge capture where applicable, waste capture
  • Payables and analytics — three-way match, rebate tracking, variance reporting
  • Structural models

Model Features Trade-offs

Centralized system contracting Enterprise contracts, leverage, standardization Local flexibility and physician engagement risk

  • Decentralized department buying Speed, local control Price leakage, SKU proliferation
  • Hybrid Central contracts + local fulfillment Common in multi-hospital systems

GPO-anchored Group Purchasing Organization contracts and tools Need local optimization and compliance discipline

Integrated delivery / self-distribution System warehouse, private fleet Capex and logistics competence required

Clinical value analysis (or product evaluation committees) bridges supply chain and clinicians: evidence, outcomes, total cost of care, and training burden—not only unit price. Pharmacy supply chain often has dual governance with pharmacy leadership because of formulary, controlled substances, and 340B where applicable.

Information systems

Modern supply chains depend on ERP/MMIS , item masters, contract catalogs, barcode/RFID, OR preference-card systems, and analytics linking implants to cases and payers. Dirty item masters (duplicate SKUs, wrong UOMs) quietly destroy compliance reporting and inventory accuracy. Executives should ask whether data quality is treated as a control environment issue.

Monitoring Effectiveness

You cannot manage what you do not measure. Common effectiveness metrics :

  • Domain Example metrics
  • Cost Supply cost per case/DRG, purchase-price variance, contract savings realized
  • Compliance % off-contract spend, physician preference-item leakage
  • Service Fill rate, stockout rate, OR case delay due to supplies
  • Inventory Turns, days on hand, expired waste, PAR accuracy
  • Quality / risk Recall response time, sterile processing instrument availability, substitute clinical risk
  • Working capital Inventory dollars, consignment vs. owned mix
  • Resilience Dual-source coverage for critical SKUs, buffer stock policies

Benchmarking against peers helps, but case mix and service-line mix must be adjusted—cardiac implant costs are not comparable to medical-surgical floor spend without context. Dashboards should distinguish price , utilization , and mix effects. A “savings” claim that only shifts cost to a higher-complication product is not a win.

Operational reviews often include:

  • Monthly supply variance with service-line leaders
  • Value analysis pipeline (products under review, conversions, clinician exceptions)
  • Critical inventory and backorder escalation
  • Vendor performance scorecards (OTIF—on time in full, quality escapes, service)
  • Strategic Decisions

Executives face recurring strategic choices:

Standardization vs. preference. Standardizing implants, energy devices, or wound-care kits can reduce cost and training variation. Forcing change without clinical evidence and surgeon champions fails and may increase complications or leakage to other sites.

Single source vs. multi-source. Single-source can maximize price and service commitments; multi-source improves resilience and leverage. Critical categories (contrast media, certain drugs, PPE, blood products interfaces) deserve dual-source or validated alternatives.

GPO vs. local negotiation. GPOs provide scale contracts; local deals or regional collaboratives may beat GPO on selected categories. The strategy is portfolio management, not ideology.

Owned inventory vs. consignment / vendor-managed inventory (VMI). Consignment reduces working capital for high-cost implants but needs tight implant logging and charge capture. VMI can improve service if governance and data sharing are strong.

Make vs. buy / outsourcing. Sterile processing, laundry, distribution, and procurement BPO are candidates. Outsourcing does not outsource accountability for patient impact and regulatory readiness.

Resilience investment. After COVID-era disruptions, many systems explicitly budget strategic reserves, nearshoring where feasible, and scenario planning for PPE and drugs. Lowest unit cost that assumes infinite supply is incomplete analysis.

Sustainability and ethics. Packaging waste, reprocessing of devices (where safe and allowed), and supplier diversity goals increasingly appear in board ESG and community expectations. They must be balanced with infection control and FDA/regulatory constraints.

Clinical and Financial Linkages

Supply chain is a finance topic because it hits expense, inventory on the balance sheet, and cash. It is a quality topic because product selection and availability affect outcomes. It is an operations topic because case flow depends on trays and implants being ready. FACHE candidates should be able to walk a board through how a 5% reduction in implant cost per joint replacement improves contribution margin—and how a two-hour stockout cancels four cases and revenue.

Physician engagement remains the hinge. Data on outcomes and total cost, peer comparison, and shared savings or service-line margin transparency beat pure edicts. Compliance programs must also watch vendor relationships , speaking fees, and sample practices that can create compliance risk.

FACHE Application

For F13 , emphasize systems (people, process, technology), structures (central/local/GPO), monitoring (cost, service, inventory, quality), and strategy (standardization, sourcing, resilience). Avoid equating supply chain solely with “getting a better price on gauze.”